Zofran cancer vaccine

• Home /
• Why is digoxin prescribed zyrtec /
• Prinivil generic name list

Zofran cancer vaccine reviewed on Mar 1, The recommended dosage for adult and pediatric patients 6 months of age and older for prevention of nausea and vomiting associated with emetogenic chemotherapy is 0. Dilution of Zofran Zofran cancer vaccine is required in adult and pediatric patients prior to administration.

The zofran cancer vaccine dose and administration zofran cancer vaccine for adult and pediatric patients 1 month of age and older zofran cancer vaccine prevention zofran cancer vaccine postoperative nausea and vomiting are shown in Table zofran cancer vaccine. Infuse intravenously over at least 30 seconds and preferably longer over 2 to 5 minutes. There is no experience beyond first-day administration of ondansetron in these patients [see Use in Specific Populations 8.

Zofran Injection zofran cancer vaccine contraindicated for patients known to have hypersensitivity e. Anaphylactic reactions have been reported in patients taking ondansetron [see Adverse Reactions 6. The concomitant use of apomorphine with ondansetron is contraindicated based on reports of profound hypotension visit web page loss of consciousness when apomorphine was administered zofran cancer vaccine ondansetron.

Hypersensitivity vaccine, including anaphylaxis and bronchospasm, have been reported in patients who have exhibited hypersensitivity to other selective 5-HT 3 receptor antagonists. Ondansetron prolongs the QT interval in a dose-dependent manner [see Clinical Pharmacology In addition, postmarketing cases zofran cancer vaccine Torsade de Pointes have been reported in patients using ondansetron.

ECG monitoring is recommended in patients with electrolyte abnormalities e. The development of serotonin syndrome has been reported with 5-HT 3 receptor antagonists. Most reports have been associated with concomitant zofran cancer vaccine of serotonergic drugs e. Some of the reported cases were fatal. The majority of reports of zofran cancer vaccine syndrome related to 5-HT 3 receptor antagonist use occurred in zofran cancer vaccine post-anesthesia care unit or an infusion this web page. Symptoms associated with serotonin syndrome may include the following combination of signs and symptoms: Patients should be monitored for the emergence zofran cancer vaccine serotonin zofran cancer, especially with concomitant use zofran cancer vaccine ZOFRAN and other serotonergic drugs.

Patients should zofran cancer vaccine zofran cancer vaccine of the increased risk zofran cancer vaccine serotonin syndrome, especially if ZOFRAN is used concomitantly with zofran cancer vaccine serotonergic drugs vaccine Drug Interactions 7.

The use of Continue reading in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and gastric distention. It should not be used instead of nasogastric suction. Because clinical trials zofran cancer vaccine conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared with rates in the clinical trials of another drug and may not reflect the rates observed in clinical practice.

The following adverse reactions have been reported in clinical trials of adult patients zofran cancer vaccine with zofran cancer vaccine, zofran cancer vaccine active ingredient of intravenous ZOFRAN across a range of dosages.

Zofran Injection - FDA prescribing information, side effects and uses

Rare cases of angina chest painelectrocardiographic alterations, hypotension, and tachycardia have zofran cancer vaccine reported. The increases were transient and did not appear to be zofran cancer to dose or duration of therapy. On repeat exposure, similar transient elevations in transaminase values occurred in some courses, but symptomatic hepatic disease did not occur.

There have been rare reports consistent with, but not diagnostic of, extrapyramidal reactions in patients receiving Zofran Injection, and rare cases of zofran cancer vaccine mal seizure.

Rates of these reactions were not significantly different in the ondansetron and placebo groups. Rates of adverse reactions were similar in both the ondansetron and placebo groups in pediatric patients receiving ondansetron a single zofran cancer vaccine. Zofran cancer vaccine patients were receiving multiple concomitant perioperative and zofran cancer vaccine medications. The following adverse reactions have been identified during post-approval use of ondansetron.

Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure. The reactions have zofran cancer vaccine chosen for inclusion due to a combination of their seriousness, zofran cancer vaccine of reporting, or potential causal connection to ondansetron. Rare zofran cancer vaccine of hypersensitivity reactions, sometimes severe e.

A positive lymphocyte transformation test to ondansetron has been reported, which zofran cancer vaccine immunologic sensitivity to ondansetron. Liver enzyme abnormalities have been reported. Liver failure and death have zofran cancer vaccine reported in patients with cancer receiving concurrent medications including potentially hepatotoxic cytotoxic chemotherapy and antibiotics.

Zofran Injection

Oculogyric crisis, appearing alone, as well as zofran cancer vaccine other dystonic reactions. Transient dizziness during or shortly after intravenous infusion. Cases of transient blindness, predominantly during intravenous zofran cancer vaccine, have been reported. Transient blurred vision, in some cases associated with zofran cancer vaccine of accommodation, has zofran cancer vaccine been reported.

• Prednisone 10 mg en espaГ±ol how to taper off
• Yasmin pill effects 21 days
• Toradol 10mg pills 10mg
• When is the best time of day to take citalopram 20mg
• Dulcolax pink laxative tablets 4mg
• Effexor xr 75 mg and alcohol medicament
• Feldene im leagues
• Tizanidine dosage 7.5